Zero Candida Technologies, Inc. (TSXV:ZCT)

Canada flag Canada · Delayed Price · Currency is CAD
0.1500
-0.0300 (-16.67%)
At close: Jul 20, 2026
Market Cap2.94M -28.6%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out 19.63M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume500
Open0.1500
Previous Close0.1800
Day's Range0.1500 - 0.1500
52-Week Range0.1100 - 0.2800
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Zero Candida Technologies

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada. [Read more]

Sector Healthcare
CEO Eli Ben-Haroosh
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol ZCT
Full Company Profile

News

Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact

VANCOUVER, BC, June 24, 2026 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company advancing next-generation ...

27 days ago - PRNewsWire

Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device

Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 women VANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: ...

5 months ago - PRNewsWire

Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device

VANCOUVER, BC , Oct. 20, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc.  (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company focused on revolutionizi...

9 months ago - PRNewsWire

Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update

VANCOUVER, BC , Sept. 3, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a Femtech company developing a SMART, AI-driven medical de...

11 months ago - PRNewsWire

Zero Candida Technologies to Present at the OTCQB Venture Virtual Investor Conference on August 7th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...

1 year ago - GlobeNewsWire

Zero Candida Technologies Announces DTC Eligibility and to Present at OTCQB Venture Virtual Investor Conference on August 7th

VANCOUVER, BC , Aug. 5, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing women's he...

1 year ago - PRNewsWire

OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

1 year ago - GlobeNewsWire

Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights

VANCOUVER, BC , April 2, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc . (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing women's ...

1 year ago - PRNewsWire